Rawlins Wayne S, Toscano-Garand Michele A, Graham Garth
Office of the Chief Medical Officer, Hartford, Connecticut 06156, USA.
Aetna Foundation, Aetna Inc., Hartford, Connecticut 06156, USA.
J Educ Health Promot. 2017 May 5;6:22. doi: 10.4103/jehp.jehp_27_15. eCollection 2017.
The purpose of this study was to evaluate diabetes control, as measured by hemoglobin A1c (HbA1c) improvements among African American and Hispanic patients receiving conventional clinical treatment combined with a bilingual diabetes educator using culturally and linguistically appropriate educational materials. This study also sought to estimate the healthcare cost savings resulting from any A1c improvements and assess the cost-effectiveness of this approach.
This was a multistage, face-to-face observational study undertaken in Texas, United States and focused on 153 African American and Hispanic patients with poor blood glucose control (baseline A1c >8.0%). For two years, a bilingual care coordinator motivated patient behavior changes that could lead to improvements in glucose control. The primary evaluation measure was change in %HbA1c, with secondary measures being change in blood pressure (BP) and low-density lipoprotein (LDL). We also sought to gauge the program's potential cost-effectiveness.
Within the study group, A1c levels decreased over the study period from a mean of 10.0% to 8.4%. The same group saw no statistically significant improvement (reduction) in blood concentrations of LDL. The African American subgroup had a small reduction in systolic BP while changes for non-White Hispanics were not statistically significant. The average A1c reduction realized in this observational study provided estimated cost savings that are nearly twice pilot expenditures.
Combining standard diabetes care with a bilingual educational care coordinator results in significant reductions in mean A1c (-1.6% HbA1c) in patients with poorly controlled blood glucose and African American/non-White Hispanic heritage, an intervention that also was shown to be cost-effective. This may be an effective model for improving diabetes care in provider practices.
本研究旨在评估接受传统临床治疗并结合使用具有文化和语言适应性教育材料的双语糖尿病教育者的非裔美国人和西班牙裔患者的糖尿病控制情况,以糖化血红蛋白(HbA1c)改善情况为衡量指标。本研究还试图估算因HbA1c改善而节省的医疗成本,并评估该方法的成本效益。
这是一项在美国得克萨斯州进行的多阶段面对面观察性研究,重点关注153名血糖控制不佳(基线HbA1c>8.0%)的非裔美国人和西班牙裔患者。两年来,一名双语护理协调员促使患者改变行为,从而改善血糖控制。主要评估指标是HbA1c百分比的变化,次要指标是血压(BP)和低密度脂蛋白(LDL)的变化。我们还试图评估该项目的潜在成本效益。
在研究组中,研究期间HbA1c水平从平均10.0%降至8.4%。同一组患者的LDL血液浓度没有统计学上的显著改善(降低)。非裔美国亚组的收缩压略有降低,而非白人西班牙裔的变化没有统计学意义。在这项观察性研究中实现的平均HbA1c降低估计节省的成本几乎是试点支出的两倍。
将标准糖尿病护理与双语教育护理协调员相结合,可使血糖控制不佳且具有非裔美国人/非白人西班牙裔血统的患者的平均HbA1c显著降低(-1.6% HbA1c),该干预措施还被证明具有成本效益。这可能是改善医疗机构糖尿病护理的有效模式。